Myomo Net Worth
Myomo Net Worth Breakdown | MYO |
Myomo Net Worth Analysis
Myomo's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Myomo's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Myomo's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Myomo's net worth analysis. One common approach is to calculate Myomo's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Myomo's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Myomo's net worth. This approach calculates the present value of Myomo's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Myomo's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Myomo's net worth. This involves comparing Myomo's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Myomo's net worth relative to its peers.
Enterprise Value |
|
To determine if Myomo is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Myomo's net worth research are outlined below:
| Myomo Inc appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 19.24 M. Reported Net Loss for the year was (8.15 M) with profit before taxes, overhead, and interest of 10.25 M. | |
| Myomo Inc has about 5.35 M in cash with (6.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: HC Wainwright Issues Pessimistic Estimate for Myomo Earnings - MarketBeat |
Myomo uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Myomo Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Myomo's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Follow Myomo's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 157.88 M.Market Cap |
|
Project Myomo's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.56) | (0.59) | |
| Return On Capital Employed | (0.90) | (0.95) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (0.91) | (0.95) |
When accessing Myomo's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Myomo's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Myomo's profitability and make more informed investment decisions.
Evaluate Myomo's management efficiency
Myomo Inc has Return on Asset of (0.3145) % which means that on every $100 spent on assets, it lost $0.3145. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8254) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.59. In addition to that, Return On Capital Employed is likely to drop to -0.95. At this time, Myomo's Net Tangible Assets are very stable compared to the past year. As of the 29th of November 2024, Non Currrent Assets Other is likely to grow to about 97 K, while Total Assets are likely to drop about 10.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.30 | 0.29 | |
| Tangible Book Value Per Share | 0.30 | 0.29 | |
| Enterprise Value Over EBITDA | (17.54) | (18.42) | |
| Price Book Value Ratio | 16.44 | 17.26 | |
| Enterprise Value Multiple | (17.54) | (18.42) | |
| Price Fair Value | 16.44 | 17.26 | |
| Enterprise Value | 141.5 M | 148.6 M |
The strategic vision of Myomo Inc management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 6.0024 | Revenue 25.2 M | Quarterly Revenue Growth 0.813 | Revenue Per Share 0.835 | Return On Equity (0.83) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Myomo insiders, such as employees or executives, is commonly permitted as long as it does not rely on Myomo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Myomo insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Myomo Corporate Filings
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 18th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 26th of August 2024 Other Reports | ViewVerify |
Myomo Earnings per Share Projection vs Actual
Myomo Corporate Executives
Elected by the shareholders, the Myomo's board of directors comprises two types of representatives: Myomo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myomo. The board's role is to monitor Myomo's management team and ensure that shareholders' interests are well served. Myomo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myomo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Henry | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.